STEROFUNDIN ISO SOLUTION FOR INFUSION [SIN13890P]
Active ingredients: STEROFUNDIN ISO SOLUTION FOR INFUSION
Last updated 24 April 2026
Product Info
STEROFUNDIN ISO SOLUTION FOR INFUSION
[SIN13890P]
Product information
Active Ingredient and Strength | CALCIUM CHLORIDE DIHYDRATE - 0.3675 G/1,000 ML |
Dosage Form | INFUSION, SOLUTION |
Manufacturer and Country | B.BRAUN MELSUNGEN AG - GERMANY |
Registration Number | SIN13890P |
Licence Holder | B. BRAUN SINGAPORE PTE LTD |
Forensic Classification | GENERAL SALE LIST |
Anatomical Therapeutic Chemical (ATC) code | NA |
Prescription-only Medicines with Exemptions for Supply without Prescription | NA |
Indication
Indications
Replacement of extracellular fluid losses in the case of isotonic dehydration, where acidosis is present or imminent.
Dosing
Dosage
Adults, the elderly, adolescents and children:
The dosage depends on the age, weight, clinical and biological conditions of the patient and concomitant therapy.
Recommended dosage:
The recommended dosage is:
for adults, the elderly and adolescents : 500 ml to 3 litres /24h, corresponding to 1 to 6 mmol sodium / kg / 24 h and 0.03 to 0.17 mmol potassium / kg / 24 h.
for babies and children : 20 ml to 100 ml / kg / 24 h, corresponding to 3 to 14 mmol sodium / kg / 24 h and 0.08 to 0.40 mmol potassium / kg / 24 h.
Administration rate:
The maximum infusion rate depends on the needs of the patient in fluid replacement and electrolytes, his weight, clinical condition, and biological status.
In paediatric patients the infusion rate is 5 ml/kg/h on average but the value varies with age: 6–8 ml/kg/h for infants, 4–6 ml/kg/h for toddlers, and 2–4 ml/kg/h for schoolchildren.
Note:
infants and toddlers: age ranges from about 28 days to 23 months (a toddler is an infant who can walk)
children and schoolchildren: age ranges from about 2 years to 11 years.
Method of administration
For intravenous use as infusion only.
The solution has a pH of 5.1 – 5.9 and a theoretical osmolarity of 309 mosm/l. Therefore it can be infused into peripheral veins.
If administration is by rapid infusion under pressure, all air must be withdrawn from the plastic container and infusion set prior to infusion, as otherwise there is a risk of producing air embolism during infusion.
Monitoring
Fluid balance, plasma electrolyte concentrations and pH must be monitored during administration.
Sterofundin ISO may be administered as long as there is an indication for fluid replacement.
Contraindications
Contraindications
Hypervolaemia
Severe congestive cardiac failure
Renal failure with oliguria or anuria
Severe general oedema
Hyperkalaemia
Hypercalcaemia
Metabolic alkalosis